Summary
Latest filing:
BIOS Fund I, LP is Director, 10% Owner of ACTUATE THERAPEUTICS, INC. (ACTU). 1 SEC Form 4 filing on record, dated 30 October 2026.
Trading pattern
InsiderAlpha's records for BIOS Fund I, LP go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies BIOS Fund I, LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd S. Thomson - $1.62M in ACTU purchases and sales in the last 12 months
- Daniel M. Schmitt - $50K in ACTU purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is BIOS Fund I, LP?
BIOS Fund I, LP is an investment firm, tracked as Director, 10% Owner of ACTUATE THERAPEUTICS, INC. (ACTU). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has BIOS Fund I, LP submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.